• Thomas Hughes leaves Zafgen to take CEO role at Navitor fiercebiotech
    August 06, 2018
    Thomas Hughes, Ph.D., has left Zafgen to become CEO at mTORC1 startup Navitor Pharmaceuticals. Hughes helmed Zafgen through a turbulent time in which it abandoned its lead candidate after patients died in a phase 3 study.
PharmaSources Customer Service